Consultants Forum Advertise
Subscribe
Close

  • Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues

Subscribe Now
Renew

Area Development - Site Selection, Facility Planning and Workforce Development

Contigo Compounding and Infusion Pharmacy Plans Albuquerque, New Mexico, Production Complex

07/21/2021
Contigo Compounding and Infusion Pharmacy is constructing a pharmaceutical manufacturing complex in Albuquerque, New Mexico. The project is expected to create 22 full-time jobs over the next five years.

The pharmacy is investing $1.3 million for plumbing, electrical HVAC, windows, doors, fixtures, retail space, and patient treatment rooms. The facility is expected to open by the end of July.

“These medications are highly specialized and very unique to the patients. If the doctors decide this is the best approach for the patients, we can now provide these services, like sterile compounding, right here in Albuquerque,” Pharmacist and co-owner Christopher Smith said.

Contigo Compounding was awarded a $150,000 grant from the Economic Development Department’s LEDA job-creation fund allows the owners to finish work and open faster with more patient options. The business has also received assistance through the Job Training Incentive Program (JTIP) to offset training costs for new employees.

“We’re not big pharma,” said David Newman, president of Contigo Compounding and Infusion Pharmacy. “The state grant is a really big deal for us. It allows the business to move forward quickly, with all the resources in hand, so we can hire employees and open with full operations.”

The expansion comes after Contigo owners saw the need for an independently-owned compounding pharmacy for sterile compounding services in Albuquerque, state officials said. Individualized compounding can help solve problems for patients that have personalized medications needs that cannot be met by a chain pharmacy. Customizations that patients and providers require include producing medication in a strength or dosage that is not commercially available, flavoring a medication to make it more palatable to a child or pet, reformulating a drug that contains a non-essential ingredient that causes an allergy for the patient, and changing the form of the drug for patient, such as a pill to a liquid, for a patient that cannot swallow.

“This is another great example of how the Economic Development Department continues to work with and help expand our local economic base businesses," Economic Development Department Cabinet Secretary Alicia J. Keyes said. "It’s these types of expansions that are the key to growing and diversifying New Mexico's economy.”

Exclusive Research